The full article “Long-term outcomes of active surveillance after #DOTATATE PET/MRI–confirmed gross total resection in WHO grade 2 #meningioma” is now available.
Read the article in #NeuroOncology Advances: bit.ly/4qQR4gn
Read the article in #NeuroOncology Advances: bit.ly/4qQR4gn
January 16, 2026 at 10:10 AM
The full article “Long-term outcomes of active surveillance after #DOTATATE PET/MRI–confirmed gross total resection in WHO grade 2 #meningioma” is now available.
Read the article in #NeuroOncology Advances: bit.ly/4qQR4gn
Read the article in #NeuroOncology Advances: bit.ly/4qQR4gn
Happy (belated) cranioversary!
My first craniotomy surgery for intra osseous spheno orbital meningioma was 6 years ago on the 21st.
My first craniotomy surgery for intra osseous spheno orbital meningioma was 6 years ago on the 21st.
January 15, 2026 at 10:04 PM
Happy (belated) cranioversary!
My first craniotomy surgery for intra osseous spheno orbital meningioma was 6 years ago on the 21st.
My first craniotomy surgery for intra osseous spheno orbital meningioma was 6 years ago on the 21st.
cw: earnest-posting
A friend and colleague of mine had her third brain surgery (recurrent meningioma) yesterday morning and neither she nor her husband has posted an update for people yet, so if you’ve got good energy to spare feel free to put it in the direction of Cincinnati.
A friend and colleague of mine had her third brain surgery (recurrent meningioma) yesterday morning and neither she nor her husband has posted an update for people yet, so if you’ve got good energy to spare feel free to put it in the direction of Cincinnati.
January 15, 2026 at 9:20 PM
cw: earnest-posting
A friend and colleague of mine had her third brain surgery (recurrent meningioma) yesterday morning and neither she nor her husband has posted an update for people yet, so if you’ve got good energy to spare feel free to put it in the direction of Cincinnati.
A friend and colleague of mine had her third brain surgery (recurrent meningioma) yesterday morning and neither she nor her husband has posted an update for people yet, so if you’ve got good energy to spare feel free to put it in the direction of Cincinnati.
“At least it’s benign.”
For Amanda, those words didn’t match the reality of living with a #braintumor. She shares why benign is not fine and how her #meningioma diagnosis had a lasting impact on her life.
Read Amanda’s story: https://braintumor.org/news/how-a-benign-brain-tumor-reshaped-my-life/
For Amanda, those words didn’t match the reality of living with a #braintumor. She shares why benign is not fine and how her #meningioma diagnosis had a lasting impact on her life.
Read Amanda’s story: https://braintumor.org/news/how-a-benign-brain-tumor-reshaped-my-life/
January 14, 2026 at 5:53 PM
“At least it’s benign.”
For Amanda, those words didn’t match the reality of living with a #braintumor. She shares why benign is not fine and how her #meningioma diagnosis had a lasting impact on her life.
Read Amanda’s story: https://braintumor.org/news/how-a-benign-brain-tumor-reshaped-my-life/
For Amanda, those words didn’t match the reality of living with a #braintumor. She shares why benign is not fine and how her #meningioma diagnosis had a lasting impact on her life.
Read Amanda’s story: https://braintumor.org/news/how-a-benign-brain-tumor-reshaped-my-life/
Identification of <em>BAP1</em> Germline Mutation in a Pediatric Patient With Skull Base Meningioma
Identification of <em>BAP1</em> Germline Mutation in a Pediatric Patient With Skull Base Meningioma
News update via NF Bot
pubmed.ncbi.nlm.nih.gov
January 13, 2026 at 3:42 PM
Identification of <em>BAP1</em> Germline Mutation in a Pediatric Patient With Skull Base Meningioma
Context-specific targeting of focal adhesion kinase in brain tumors: lessons from glioblastoma and neurofibromatosis type 2-mutant meningioma
Context-specific targeting of focal adhesion kinase in brain tumors: lessons from glioblastoma and neurofibromatosis type 2-mutant meningioma
News update via NF Bot
pubmed.ncbi.nlm.nih.gov
January 13, 2026 at 3:42 PM
Context-specific targeting of focal adhesion kinase in brain tumors: lessons from glioblastoma and neurofibromatosis type 2-mutant meningioma
Clinicopathological and molecular characteristics of clear cell meningioma: analyses of seventeen cases
Clinicopathological and molecular characteristics of clear cell meningioma: analyses of seventeen cases
News update via NF Bot
pubmed.ncbi.nlm.nih.gov
January 13, 2026 at 3:41 PM
Clinicopathological and molecular characteristics of clear cell meningioma: analyses of seventeen cases
Pediatric meningioma and seizures: a single-center cohort study
Pediatric meningioma and seizures: a single-center cohort study
News update via NF Bot
pubmed.ncbi.nlm.nih.gov
January 13, 2026 at 3:41 PM
Pediatric meningioma and seizures: a single-center cohort study
Since my doctors told me about my meningioma, I can’t help but wonder if my migraines aren’t migraines. They say it’s not doing anything but why am I dizzy 24/7??
January 13, 2026 at 3:17 PM
Since my doctors told me about my meningioma, I can’t help but wonder if my migraines aren’t migraines. They say it’s not doing anything but why am I dizzy 24/7??
Pediatric meningioma and seizures: a single-center cohort study
Pediatric meningioma and seizures: a single-center cohort study
News update via NF Bot
pubmed.ncbi.nlm.nih.gov
January 13, 2026 at 5:39 AM
Pediatric meningioma and seizures: a single-center cohort study
Mark your calendars! The 100th Anniversary Meeting of the Society of British Neurological Surgeons will be taking place 12th-16th October 2026, and will include joint #ICOM-#BIMS (British Irish #Meningioma Society) sessions.
Find out more here: bit.ly/4pvKifo
Find out more here: bit.ly/4pvKifo
January 12, 2026 at 10:55 AM
Mark your calendars! The 100th Anniversary Meeting of the Society of British Neurological Surgeons will be taking place 12th-16th October 2026, and will include joint #ICOM-#BIMS (British Irish #Meningioma Society) sessions.
Find out more here: bit.ly/4pvKifo
Find out more here: bit.ly/4pvKifo
⭐ Huge congrats to our survivor marathoner (acoustic neuroma & meningioma) for showing incredible strength on the course.
🙏 Thank you to NBTS staff, Focus Partners, and the Nathanson family for making this weekend magical.
💫 Together, our entire team raised over $164,466+ in support of NBTS
🙏 Thank you to NBTS staff, Focus Partners, and the Nathanson family for making this weekend magical.
💫 Together, our entire team raised over $164,466+ in support of NBTS
January 11, 2026 at 9:56 PM
⭐ Huge congrats to our survivor marathoner (acoustic neuroma & meningioma) for showing incredible strength on the course.
🙏 Thank you to NBTS staff, Focus Partners, and the Nathanson family for making this weekend magical.
💫 Together, our entire team raised over $164,466+ in support of NBTS
🙏 Thank you to NBTS staff, Focus Partners, and the Nathanson family for making this weekend magical.
💫 Together, our entire team raised over $164,466+ in support of NBTS
Today, we’re celebrating 33 incredible #GNE runners taking on the 2026 Walt Disney World® Half Marathon with strength, purpose, and heart.
Our team includes 6 survivors representing meningioma, chordoma, pituitary tumor, pituitary macroprolactinoma, and choroid plexus.
Our team includes 6 survivors representing meningioma, chordoma, pituitary tumor, pituitary macroprolactinoma, and choroid plexus.
January 10, 2026 at 7:37 PM
Today, we’re celebrating 33 incredible #GNE runners taking on the 2026 Walt Disney World® Half Marathon with strength, purpose, and heart.
Our team includes 6 survivors representing meningioma, chordoma, pituitary tumor, pituitary macroprolactinoma, and choroid plexus.
Our team includes 6 survivors representing meningioma, chordoma, pituitary tumor, pituitary macroprolactinoma, and choroid plexus.
Today we’re celebrating 27 amazing #GNE runners taking on the 2026 Walt Disney World® 10K, sponsored by State Farm with heart, strength, and purpose.
Our team proudly includes 2 survivors representing meningioma and Grade IV astroblastoma—true inspiration every step of the way.
Our team proudly includes 2 survivors representing meningioma and Grade IV astroblastoma—true inspiration every step of the way.
January 10, 2026 at 3:31 AM
Today we’re celebrating 27 amazing #GNE runners taking on the 2026 Walt Disney World® 10K, sponsored by State Farm with heart, strength, and purpose.
Our team proudly includes 2 survivors representing meningioma and Grade IV astroblastoma—true inspiration every step of the way.
Our team proudly includes 2 survivors representing meningioma and Grade IV astroblastoma—true inspiration every step of the way.
🧬 Meningioma - Dec 2025
• Liquid biopsy and imaging models push non-invasive diagnosis forward
• Tumor biomechanics, blood flow, and dural context emerge as key surgical variables
• Unexpected signals from intratumoral microbiomes
pir.sh/qmxdxp6dyp
#NeuroOncology #Meningioma #BrainTumors
• Liquid biopsy and imaging models push non-invasive diagnosis forward
• Tumor biomechanics, blood flow, and dural context emerge as key surgical variables
• Unexpected signals from intratumoral microbiomes
pir.sh/qmxdxp6dyp
#NeuroOncology #Meningioma #BrainTumors
Summarized Science - Research on Meningioma in December of 2025
Latest research highlights and monthly summaries for Meningioma. AI-powered analysis of the latest scientific publications and research trends.
pir.sh
January 9, 2026 at 8:29 PM
🧬 Meningioma - Dec 2025
• Liquid biopsy and imaging models push non-invasive diagnosis forward
• Tumor biomechanics, blood flow, and dural context emerge as key surgical variables
• Unexpected signals from intratumoral microbiomes
pir.sh/qmxdxp6dyp
#NeuroOncology #Meningioma #BrainTumors
• Liquid biopsy and imaging models push non-invasive diagnosis forward
• Tumor biomechanics, blood flow, and dural context emerge as key surgical variables
• Unexpected signals from intratumoral microbiomes
pir.sh/qmxdxp6dyp
#NeuroOncology #Meningioma #BrainTumors
Open Access UCL Research: A Label-Free Hyperspectral Imaging Device for Ex Vivo Characterization and Grading of Meningioma Tissues discovery.ucl.ac.uk/id/eprint/10...
A Label-Free Hyperspectral Imaging Device for Ex Vivo Characterization and Grading of Meningioma Tissues
-
UCL Discovery
UCL Discovery is UCL's open access repository, showcasing and providing access to UCL research outputs from all UCL disciplines.
discovery.ucl.ac.uk
January 9, 2026 at 4:08 PM
Open Access UCL Research: A Label-Free Hyperspectral Imaging Device for Ex Vivo Characterization and Grading of Meningioma Tissues discovery.ucl.ac.uk/id/eprint/10...
Delighted to share our research news with you.
Finding drug targets for both meningioma & vestibular schwannoma. We have identified 10 FDA approved drugs that are computationally predicted to reverse both meningioma & VS to a healthy tissue state
link.springer.com/epdf/10.1186...
#ENDNF2
Finding drug targets for both meningioma & vestibular schwannoma. We have identified 10 FDA approved drugs that are computationally predicted to reverse both meningioma & VS to a healthy tissue state
link.springer.com/epdf/10.1186...
#ENDNF2
January 8, 2026 at 11:29 AM
Delighted to share our research news with you.
Finding drug targets for both meningioma & vestibular schwannoma. We have identified 10 FDA approved drugs that are computationally predicted to reverse both meningioma & VS to a healthy tissue state
link.springer.com/epdf/10.1186...
#ENDNF2
Finding drug targets for both meningioma & vestibular schwannoma. We have identified 10 FDA approved drugs that are computationally predicted to reverse both meningioma & VS to a healthy tissue state
link.springer.com/epdf/10.1186...
#ENDNF2
The #NASBS/#ICOM scientific day is coming up in three months!
These sessions will be highly relevant to anyone involved in #meningioma or #ArtificialIntelligence research and/or anyone who takes care of patients with #BrainTumors.
Find out more here: bit.ly/4jm1qlT
These sessions will be highly relevant to anyone involved in #meningioma or #ArtificialIntelligence research and/or anyone who takes care of patients with #BrainTumors.
Find out more here: bit.ly/4jm1qlT
January 7, 2026 at 10:44 AM
The #NASBS/#ICOM scientific day is coming up in three months!
These sessions will be highly relevant to anyone involved in #meningioma or #ArtificialIntelligence research and/or anyone who takes care of patients with #BrainTumors.
Find out more here: bit.ly/4jm1qlT
These sessions will be highly relevant to anyone involved in #meningioma or #ArtificialIntelligence research and/or anyone who takes care of patients with #BrainTumors.
Find out more here: bit.ly/4jm1qlT
Clinicopathological and molecular characteristics of clear cell meningioma: analyses of seventeen cases
Clinicopathological and molecular characteristics of clear cell meningioma: analyses of seventeen cases
News update via NF Bot
pubmed.ncbi.nlm.nih.gov
January 6, 2026 at 6:39 PM
Clinicopathological and molecular characteristics of clear cell meningioma: analyses of seventeen cases
Please share....
Ladies, if you've been on Depo-Provera and haven't heard about this... please pay attention! There is a link between Depo-Provera and meningioma (a type of brain tumor). Pfizer put this warning out in OTHER countries about a decade ago!
www.thecardiologyadvisor.com/news/fda-add...
Ladies, if you've been on Depo-Provera and haven't heard about this... please pay attention! There is a link between Depo-Provera and meningioma (a type of brain tumor). Pfizer put this warning out in OTHER countries about a decade ago!
www.thecardiologyadvisor.com/news/fda-add...
FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot
The FDA approved a new safety warning for Depo-Provera alerting patients to a possible risk for a type of brain tumor called meningioma.
www.thecardiologyadvisor.com
January 5, 2026 at 10:57 PM
Please share....
Ladies, if you've been on Depo-Provera and haven't heard about this... please pay attention! There is a link between Depo-Provera and meningioma (a type of brain tumor). Pfizer put this warning out in OTHER countries about a decade ago!
www.thecardiologyadvisor.com/news/fda-add...
Ladies, if you've been on Depo-Provera and haven't heard about this... please pay attention! There is a link between Depo-Provera and meningioma (a type of brain tumor). Pfizer put this warning out in OTHER countries about a decade ago!
www.thecardiologyadvisor.com/news/fda-add...
The FDA just approved a label change for Depo-Provera, a form of birth control also known as "the shot." The updated label includes a warning about the risk of developing meningioma, a type of tumor that forms in one of the three membrane layers that cover and protect your brain.
#FDA #DepoProvera
#FDA #DepoProvera
January 5, 2026 at 8:09 PM
The FDA just approved a label change for Depo-Provera, a form of birth control also known as "the shot." The updated label includes a warning about the risk of developing meningioma, a type of tumor that forms in one of the three membrane layers that cover and protect your brain.
#FDA #DepoProvera
#FDA #DepoProvera
Getting results at all would be good, Coventry & Warwickshire pretty crap at that.
I found out by accident about 2 years afterwards that they'd found a meningioma on one of my routine MRIs. They are now supposed to check it every year on my usual annual MRI scan, I'm not convinced they do though.
I found out by accident about 2 years afterwards that they'd found a meningioma on one of my routine MRIs. They are now supposed to check it every year on my usual annual MRI scan, I'm not convinced they do though.
January 5, 2026 at 7:14 PM
Getting results at all would be good, Coventry & Warwickshire pretty crap at that.
I found out by accident about 2 years afterwards that they'd found a meningioma on one of my routine MRIs. They are now supposed to check it every year on my usual annual MRI scan, I'm not convinced they do though.
I found out by accident about 2 years afterwards that they'd found a meningioma on one of my routine MRIs. They are now supposed to check it every year on my usual annual MRI scan, I'm not convinced they do though.
I have a meningioma brain tumor. If I started talking like Fetterman it would alarm my doctors.
January 5, 2026 at 5:50 PM
I have a meningioma brain tumor. If I started talking like Fetterman it would alarm my doctors.
Context-specific targeting of focal adhesion kinase in brain tumors: lessons from glioblastoma and neurofibromatosis type 2-mutant meningioma
Context-specific targeting of focal adhesion kinase in brain tumors: lessons from glioblastoma and neurofibromatosis type 2-mutant meningioma
News update via NF Bot
pubmed.ncbi.nlm.nih.gov
January 5, 2026 at 12:39 PM
Context-specific targeting of focal adhesion kinase in brain tumors: lessons from glioblastoma and neurofibromatosis type 2-mutant meningioma
Read the accepted manuscript of a recent investigation finding that #meningioma brain invasion is defined by molecular remodeling of tumor cells and functional interactions within the tumor microenvironment:
bit.ly/3LrBsAI
@CraigHorbinski
bit.ly/3LrBsAI
@CraigHorbinski
January 5, 2026 at 11:11 AM
Read the accepted manuscript of a recent investigation finding that #meningioma brain invasion is defined by molecular remodeling of tumor cells and functional interactions within the tumor microenvironment:
bit.ly/3LrBsAI
@CraigHorbinski
bit.ly/3LrBsAI
@CraigHorbinski